First multicenter real-world analysis of switching to next-generation enzyme replacement therapies in late-onset Pompe disease.

J Neurol · 2026 · PMC12906561 · PMID 41689630

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

However, these differences did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.